Immunomedics Settles Patent Suit Vs. Cytogen

Law360, New York (September 29, 2004, 12:00 AM EDT) -- Biopharma company Immunomedics, Inc. has settled its patent infringement lawsuit against Cytogen Corp. and C.R. Bard, Inc. for an undisclosed payment and without any admission of fault or liability, the companies said.

No further details of the settlement agreement were available.

The companies had been litigating their patent dispute for more than three years, taking it all the way to the U.S. Court of Appeals for the Federal Circuit, usually the highest court in the U.S. for patent cases.

Immunomedics sued Cutogen in 2000, alleging that...
To view the full article, register now.